About G1 Therapeutics (GTHX)
G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing small-molecule therapies for the treatment of cancer. Its two clinical-stage candidates are trilaciclib (G1T28) and G1T38, which are potent, sel... Read more
- USD3.95
- USD4.03
- USD3.70
- USD5.00
- -7.00%
- 83M
- 690.94k
- 746.83k
- 209M
- 1.08
- 62.20%
Stock News
2 hours ago
Dow Jones Up As Donald Trump Stock Surges; Cathie Wood Loads Up On This AI Stock Amid 26% Plunge
Yahoo
2 hours ago
KBR Awarded $771M in LOGCAP Contract Options to Provide Logistics and Life Support Services to U.S. Army EUCOM and NORTHCOM
Yahoo
2 hours ago
CFSB BANCORP, INC. ANNOUNCES FISCAL THIRD QUARTER AND YEAR-TO-DATE 2024 FINANCIAL RESULTS
Yahoo
3 hours ago
Ready Capital Corporation Announces First Quarter 2024 Results and Webcast Call
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
